Biocon Dividends and Buybacks
Dividend criteria checks 2/6
Biocon is a dividend paying company with a current yield of 0.13% that is well covered by earnings.
Key information
0.1%
Dividend yield
-7.4%
Buyback Yield
| Total Shareholder Yield | -7.3% |
| Future Dividend Yield | 0.3% |
| Dividend Growth | -1.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | 13% |
Recent dividend and buyback updates
Biocon (NSE:BIOCON) Will Pay A Dividend Of ₹0.50
Jun 18
Biocon (NSE:BIOCON) Has Affirmed Its Dividend Of ₹0.50
May 12Recent updates
Calculating The Fair Value Of Biocon Limited (NSE:BIOCON)
Dec 25Investors Don't See Light At End Of Biocon Limited's (NSE:BIOCON) Tunnel
Dec 07Weak Statutory Earnings May Not Tell The Whole Story For Biocon (NSE:BIOCON)
Nov 19Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 56% Above Its Share Price
Sep 22Biocon Limited Just Missed Earnings - But Analysts Have Updated Their Models
Aug 10Pinning Down Biocon Limited's (NSE:BIOCON) P/E Is Difficult Right Now
Aug 04Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next
Jun 19Biocon (NSE:BIOCON) Will Pay A Dividend Of ₹0.50
Jun 18Biocon (NSE:BIOCON) Has Affirmed Its Dividend Of ₹0.50
May 12Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)
Apr 18Biocon Limited's (NSE:BIOCON) Business Is Trailing The Market But Its Shares Aren't
Mar 10Does Biocon (NSE:BIOCON) Have A Healthy Balance Sheet?
Feb 20
Tactical Biosimilars Expansion And Viatris Integration Will Propel Revenue Growth And Boost Profitability
Strategic cost improvements and production efficiencies are set to enhance margins and profitability in the generics segment.Stability and Growth of Payments
Fetching dividends data
Stable Dividend: BIOCON's dividend payments have been volatile in the past 10 years.
Growing Dividend: BIOCON's dividend payments have fallen over the past 10 years.
Dividend Yield vs Market
| Biocon Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (BIOCON) | 0.1% |
| Market Bottom 25% (IN) | 0.3% |
| Market Top 25% (IN) | 1.4% |
| Industry Average (Biotechs) | 1.1% |
| Analyst forecast (BIOCON) (up to 3 years) | 0.3% |
Notable Dividend: BIOCON's dividend (0.13%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.3%).
High Dividend: BIOCON's dividend (0.13%) is low compared to the top 25% of dividend payers in the Indian market (1.44%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (12.8%), BIOCON's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (4.5%), BIOCON's dividend payments are thoroughly covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/09 06:58 |
| End of Day Share Price | 2026/02/09 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Biocon Limited is covered by 42 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Meeta Shetty | Asian Markets Securities Private Limited |
| Harith Ahamed | Avendus Spark |
| Vijayaraghavan Swaminathan | Avendus Spark |